Dilip Shanghvi

Meet Padma Shri Dilip Shanghvi, a visionary who transformed Indian healthcare industry: Know about his journey, education, net worth and more

In this article, we will take a look at Shanghvi’s journey, family, education, net worth and more.

April 29, 2023 09:00 IST

Sun Pharma announces positive results of two phase-III CTs of Tildrakizumab

The IL-23p19 Therapeutic Antibody meets primary endpoints in both placebo-controlled studies and secondary endpoint in active-comparator etanercept arm

Updated: May 4, 2016 17:52 IST

RIL’s Mukesh Ambani, Wipro’s Azim Premji, Sun’s Dilip Shanghvi in top 50 wealthiest people list: Wealth-X

Reliance Industries Mukesh Ambani, Wipro chief Azim Premji and Sun Pharmaceutical Industries’ Dilip Shanghvi, have made it to a global…

January 28, 2016 16:24 IST

Mukesh Ambani, Azim Premji, Dilip Shanghvi among world’s 50 wealthiest

The list of top 50 wealthiest people in the world have a combined fortune of $1.45 trillion, nearly equal to…

January 28, 2016 13:14 IST

‘DRILS Synergy 2015’ symposium organised

The programme saw industry leaders and academia under one roof to discuss opportunities to build a culture of innovation and…

Updated: August 31, 2015 18:20 IST

Sun Pharma posts net profit of Rs 479 crores Q1FY16

Net sales has been registered at Rs 6,522 crores Sun Pharmaceutical Industries has posted its financials for first quarter ending…

August 12, 2015 09:28 IST

Indian billionaires: Gautam Adani, Dilip Shangvhi see highest growth

Gautam Adani, 52, has added nearly $3 billion (Rs 19,000 crore) to his wealth on soaring shares of his companies.

Updated: May 31, 2015 07:54 IST

SAC-ACCP organises eighth annual international conference

Felicitates six industry stakeholders and institutions South Asian Chapter of American College of Clinical Pharmacology (SAC-ACCP) recently organised its eighth…

April 24, 2015 17:09 IST

Suzlon Energy snaps 2 day losing streak as open offer from Dilip Shanghvi begins

Shares of Suzlon Energy snapped two-day losing streak on Wednesday after Dilip Shanghvi Family and Associates…

Updated: April 16, 2015 02:11 IST

Sun Pharma announces closure of merger deal with Ranbaxy

The combined entity’s manufacturing footprint covers five continents with products sold in over 150 nations

Updated: March 25, 2015 17:23 IST

CCI approves Ranbaxy acquisition by Sun Pharma

Sun Pharma and Ranbaxy had filed the notice with the CCI on May 6, 2014 and sought its approval with…

December 9, 2014 10:32 IST

Related News

Four big companies have now stopped sponsoring H-1B visas. Here is the full list

EB-5 fees, EB-5 filing fees cut, EB-5 visa, USCIS EB-5 rule, DHS EB-5 rule, Form I-526 fee reduction, Form I-829 petition, EB-5 investor program, EB-5 technology fee, EB-5 program changes

US cuts EB-5 fees for foreign investors seeking employment-based green cards

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Aadhaar card update new rules from November 2025: You won’t need to upload documents anymore — here’s how to change your details online

UK High Potential Individual Visa, UK high potential individual visa university list, HPI visa UK, UK work visa without job offer, top global universities visa, UK graduate visa

UK High Potential Visa lets top university graduates work freely — No job offer needed

From H-1B to green card: Follow the journey of an Indian entrepreneur to $3.7 billion

Indian techie overcomes H-1B challenges, gets green card, quits job, and achieves $3.7 billion success

Jio pivoting from mobile growth to home broadband play: Analysts

Business1 hr ago

Reliance Jio’s Q2 results showed a shift towards home connectivity, with 8.3 million new users and a total of 506 million subscribers. Fixed broadband and 5G net additions were at 2.4 million and 21 million respectively. FWA and FTTH net adds were 2.1 million and 0.9 million, indicating the success of Jio’s home broadband expansion.

View all shorts